Beiley Biofund Inc. (TPEX:7882)
Taiwan · Delayed Price · Currency is TWD 23.75
-0.55 (-2.26%)
At close: Nov 6, 2026
Beiley Biofund Company Description
Beiley Biofund Inc. is a venture capital firm specializing in early-stage and late-stage investments.
The firm seeks to invest in unmet medical needs, including chronic diseases associated with aging and cancer.
It invests in biotechnology trends driven by precision medicine, artificial intelligence, and emerging platform technologies.
The firm seeks to invest in novel drugs, medical devices, healthcare services, and veterinary medicine.
Beiley Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.
Beiley Biofund Inc.
| Country | Taiwan |
| Founded | 2013 |
| Industry | Management Investment Offices, Open-End |
| CEO | Che Hsu |
Contact Details
Address: 14th Floor, No. 6, Section 1 Taipei, 10041 Taiwan | |
| Phone | 886 2 8979 5678 |
| Website | beileybiofund.com |
Stock Details
| Ticker Symbol | 7882 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0007882003 |
| SIC Code | 6722 |
Key Executives
| Name | Position |
|---|---|
| Che Hsu | Chief Executive Officer |